Thursday
Nov192009
Sino Biopharmaceutical (1177 HK): Current price is fair -HOLD (From BUY)
Thursday, November 19, 2009 at 9:47AM - 3Q FY12/09A revenue increased 54.2% to HK$901.4m and net profit was up 46.7% YoY to HK$97.7.
- New blockbuster drugs are the key growth driver.
- R&D support the long-term growth.
- Cash on hand of HK$1,846.0m and dividend payout ratio of 55.6%.
- Plan to issue one bonus share for every two existing shareholders for improving liquidity.
- DCF-derived fair value at HK$3.2, representing 20.3x and ex-cash 16.1x FY12/10F P/E. Call from BUY to HOLD

Reader Comments